|
Friday, 02 January 2009 |
|
Pharmaceutical News Watson Pharmaceuticals, Inc. has received approval from the United States Food and Drug Administration to market its over-the-counter Nicotine Polacrilex Gum USP, coated mint flavor, in the 2 mg and 4 mg strengths. |
|
Read more...
|
|
|
Friday, 02 January 2009 |
|
Pharmaceutical News Schering-Plough Corp. has announced that the European Medicines Agency (EMEA) has validated (accepted for review) its Marketing Authorization Application (MAA) for corifollitropin alfa, the company's experimental, sustained follicle stimulant (SFS). |
|
Read more...
|
|
|
Friday, 02 January 2009 |
|
Pharmaceutical News Mylan Inc. |
|
Read more...
|
|
|
Friday, 02 January 2009 |
|
Medical Science News Using small gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion. |
|
Read more...
|
|
|
Wednesday, 31 December 2008 |
|
Miscellaneous News While the emphasis right now is on urging New Year revellers to drink responsibly, many teenagers could be more likely to try drugs on New Year's Eve than any other night. |
|
Read more...
|
|
|
Wednesday, 31 December 2008 |
|
Pharmaceutical News Savient Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's Biologics License Application (BLA) for pegloticase, a novel biological drug for treatment-failure gout (TFG) patients. |
|
Read more...
|
|
|
Wednesday, 31 December 2008 |
|
Pharmaceutical News Salix Pharmaceuticals, Ltd. |
|
Read more...
|
|
|
Wednesday, 31 December 2008 |
|
Medical Research News Stem Cell Sciences plc has announced that pioneering research describing a technique for creating authentic embryonic stem (ES) cells from rats has been published in the prestigious peer-reviewed journal, Cell. |
|
Read more...
|
|
|
Wednesday, 31 December 2008 |
|
Pharmaceutical News Watson Pharmaceuticals, Inc. |
|
Read more...
|
|
|
Monday, 22 December 2008 |
|
Pharmaceutical News GlaxoSmithKline (GSK) is prepared to respond to public health requires for Relenza (zanamivir) Inhalation Powder this flu season following a Health Alert Advisory issued by the Centers for Disease Control and Prevention (CDC). |
|
Read more...
|
|
|
Monday, 22 December 2008 |
|
|
|
Read more...
|
|
|
Monday, 22 December 2008 |
|
Medical Research News MRI scans that detect shrinkage in special regions of the mid-brain attacked by Alzheimer's disease accurately diagnose the neurodegenerative disease, even before symptoms interfere with daily function, a study by the Florida Alzheimer's Disease Research Center (ADRC) in Miami... |
|
Read more...
|
|
|
Friday, 19 December 2008 |
|
Devices/Technology VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools. |
|
Read more...
|
|
|
Thursday, 18 December 2008 |
|
Medical Research News Embryonic stem cells could provide a new way of testing drugs for dangerous side effects, according to a leading British researcher. |
|
Read more...
|
|
|
Tuesday, 16 December 2008 |
|
Pharmaceutical News The U.S. Food and Drug Administration has announced it will require the manufacturers of antiepileptic drugs to add to these products' prescribing info, or labeling, a warning that their use increases risk of suicidal thoughts and behaviors (suicidality). |
|
Read more...
|
|
|
Tuesday, 16 December 2008 |
|
Medical Research News A drug used to treat multiple sclerosis might make some patients vulnerable to brain infection by reducing the number of immune cells there, researchers at UT Southwestern Medical Center have found. |
|
Read more...
|
|
|
Tuesday, 16 December 2008 |
|
Drug Trials Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthful volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead. |
|
Read more...
|
|
|
Monday, 15 December 2008 |
|
Devices/Technology MIT engineers have developed carbon nanotubes into sensors for cancer drugs and other DNA-damaging agents inside living cells. |
|
Read more...
|
|
|
Monday, 15 December 2008 |
|
Pharmaceutical News Barr Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review Duramed Pharmaceuticals, Inc.'s Adenovirus Types 4 and 7 Live Oral Vaccines Biologics License Application (BLA). |
|
Read more...
|
|
|
Monday, 15 December 2008 |
|
Child Health News Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have identified a potential new avenue for altering lung development in the embryo which may help to advance the outcome for very premature babies. |
|
Read more...
|
|
|
Friday, 12 December 2008 |
|
Medical Research News There are signs that the ongoing decline in teen marijuana use in recent years has stalled; nevertheless the downward trend in cigarette and alcohol use continues, according to the 2008 Monitoring the Future (MTF) Survey. Results were announced today at a news conference. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Medical Research News Pharmaceutical companies and universities are racing to develop drugs that use the gene silencing mechanism known as RNA interference to treat a host of diseases. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Pharmaceutical News In the treatment of pain, inflammation and fever, non-steroid anti-rheumatic drugs (NSAR) like acetylsalicylic acid - more usually known as Aspirin - or Ibuprofen have always been popular choices. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Devices/Technology Chalmers researcher Andreas Dahlin has developed a biosensor with an artificial membrane, which means that membrane-bound proteins can retain their natural structure and function. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Drug Trials AcelRx Pharmaceuticals, Inc.has announced positive results from a Phase 2 clinical study evaluating the safety and efficacy of its lead product candidate, ARX-01, for the treatment of moderate-to-severe inpatient acute pain following knee replacement surgery. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Medical Patent News Alnylam Pharmaceuticals, Inc. has announced that the European Patent Office (EPO) has ruled in favor of the Appellants in oral proceedings before the Board of Appeals related to the '623 (EP 1144623) patent in its Kreutzer-Limmer patent estate. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Drug Trials Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI). |
|
Read more...
|
|
|
Tuesday, 09 December 2008 |
|
Pharmaceutical News Clinicians using an electronic prescribing system appear more likely to prescribe lower-cost medications, reducing drug spending, according to a report in the December 8/22 issue of Archives of Internal Medicine. |
|
Read more...
|
|
|
Monday, 08 December 2008 |
|
Pharmaceutical News The U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee today voted unanimously to recommend approval of Bausch & Lomb's besifloxacin ophthalmic suspension, 0.6%, for the treatment of bacterial conjunctivitis. |
|
Read more...
|
|
|
Monday, 08 December 2008 |
|
Pharmaceutical News Azur Pharma Limited has announced that it has entered into a definitive agreement with BioSante Pharmaceuticals, Inc to acquire U.S. rights to Elestrin. |
|
Read more...
|
|
